缺血
医学
再灌注损伤
肾损伤
急性肾损伤
肾缺血
药理学
心脏病学
肾
内科学
作者
Sherief Maher,Michael Atef Fawzy,Mahmoud A. Elrehany,Moustafa Fathy
出处
期刊:
日期:2021-04-01
卷期号:32 (2): 42-49
被引量:1
标识
DOI:10.21608/mjmr.2021.231544
摘要
Ischemia/reperfusion injury (IRI) is caused by a rapid transient reduction in blood flow to a specific organ. IRI is typically accompanied by a strong inflammatory and oxidative stress response to hypoxia and reperfusion, which disrupts organ function. AKI caused by renal IRI contributes to a high morbidity and death rate in a variety of injuries. Although the pathophysiology of IRI is not fully understood, numerous key pathways leading to renal failure have been identified. The production of reactive oxygen species (ROS) during the reperfusion phase of the ischemic kidney and subsequent re-oxygenation begins a cascade of detrimental cellular reactions that lead to inflammation, cell death, and acute kidney failure. Greater knowledge of the cellular pathophysiological mechanisms causing kidney damage may lead to the development of more focused treatments to prevent and treat the damage. We discuss several significant possible mechanisms and treatment methods in renal IRI in this study.
科研通智能强力驱动
Strongly Powered by AbleSci AI